Summary
Pre-clinical drug development for paediatric cancers is very complex, resource intensive and requiring multi-disciplinary expertise and innovative approaches. The VAGABOND-ETN consists of 12 academic and 6 non-academic partners from 8 European countries and trains 15 ESRs. The...
More information & hyperlinks
Web resources: | https://vagabondnetwork.com |